|
QuintilesIMS Real-World Insights Bibliography
| Budget impact analysis of Biphasic Insulin Aspart in the treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective |
| Author(s): Tan SC1, Matzen P2, Yeo LN2 |
| Affiliations(s): 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malysia, Kuala Lumpur, Malaysia |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Poster |
| Countries: Malaysia |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Budget impact |
|
 |
| |
| |
| Estimating the Costs of Diabetes Mellitus: An Analysis in Malaysia |
| Author(s): Todorova L1, Hnoosh A2, Bloomfield E2, Shiu ML3 |
| Affiliations(s): 1 Novo Nordisk International Operations, Zurich, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia |
| Publication(s): ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan. |
| Document Type(s): Abstract |
| Countries: Malaysia |
| Click here for the abstract |
C:
Y: |
Diabetes
2012 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
| The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: India, Malaysia, Singapore, South Korea, Thailand |
C:
Y: |
Ophthalmology
2012 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. |
| Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
| Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
| Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
| Document Type(s): Abstract, Poster |
| Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand |
C:
Y: |
Ophthalmology
2012 |
|
L:
A: |
English
Burden of illness |
|
|
| |
| |
| Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas. |
| Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5 |
| Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK |
| Publication(s): European Respiratory Review 2006; 15:(98): 24-29 |
| Document Type(s): Manuscript in preparation |
| Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam |
C:
Y: |
Respiratory disease
2006 |
|
L:
A: |
English
Cost of illness |
|
|
| |
| |
|
|
|
